Study of Motexafin Gadolinium (MGd) for Second Line Treatment of Non-Small-Cell Lung Cancer

Clinical trial NCT00129844 · COMPLETED

Trial details

NCT number: NCT00129844
Sponsor: Pharmacyclics LLC.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Adenocarcinoma Non-Small-Cell Lung Carcinoma Lung Neoplasms

Start date: 2005-09-01
Primary completion: 2007-06-01
Enrollment: 108

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.